Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.

Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.

Item
http://www.wikidata.org/entity/Q37432115
Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockadeBeta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.Profile of mirabegron in the treatment of overactive bladder: place in therapy.A drug safety evaluation of mirabegron in the management of overactive bladder.Mirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder populations, and patients with OAB in Asia.Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction?The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: New therapeutic indication?
P2860

Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.

Item
http://www.wikidata.org/entity/Q37432115
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@en
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@nl
type
label
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@en
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@nl
prefLabel
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@en
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Pharmacokinetics of mirabegron ...... le- and multiple-dose studies.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932